Biomarin Pharmaceutical Inc (BMRN)

66.83 +0.34 (+0.51%) USD  |  NASDAQ  |  Jan 03, 16:00
66.86 +0.02 (+0.04%) After-Hours: 20:00
More

Biomarin Pharmaceutical EPS Diluted from Other Gain/Loss (Quarterly)

EPS Diluted from Other Gain/Loss (Quarterly) Chart

View EPS Diluted from Other Gain/Loss (Quarterly) for BMRN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted from Other Gain/Loss (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted from Other Gain/Loss (Quarterly) Range, Past 5 Years

View EPS Diluted from Other Gain/Loss (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted from Other Gain/Loss (Quarterly) Benchmarks

View EPS Diluted from Other Gain/Loss (Quarterly) Benchmarks
Start Trial
Pfizer Inc --
Merck & Co Inc --
Biogen Inc --
Bristol-Myers Squibb Co --
Moderna Inc --